Furthermore, the dual-targeting capability of GrB, against both cancer cells and bacteria, has been observed, with GrB demonstrating the ability to target and kill bacteria by entering their cytosol, thereby attenuating bacterial virulence. This evidence concerns the gene GZMB and cancer.